1. Lazarou, J., Pomeranz, B. H. & Corey, P. N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279, 1200–1205 (1998).
2. Flanagan, A. Screening technologies evolve: innovations spurred by race to profit from genetic data. Genet. Eng. News 20, 1, 19–20, 71 ( September 1, 2000).
3. Barrett, A. The pharma frenzy: in the race for gene-based therapies, big drugmakers join forces with upstarts. Business Week 160– 161 (June 2000).
4. Roses, A. D. Pharmacogenetics and the practice of medicine. Nature 405, 857–865 (2000).
5. Noah, B. A. Adverse drug reactions: harnessing experiential data to promote patient welfare . Catholic U. Law Rev. 49, 449– 504 (2000).